Old Web
English
Sign In
Acemap
>
Paper
>
PO-169 The Phase l/ll ACCEPT Trial: Cetuximab and IMRT with Carbon Ion Boost for Adenoid Cystic Carcinoma
PO-169 The Phase l/ll ACCEPT Trial: Cetuximab and IMRT with Carbon Ion Boost for Adenoid Cystic Carcinoma
2019
S. Adeberg
Alexandra D. Jensen
Sati Akbaba
Sonja Katayama
Vivek Verma
Denise Bernhardt
Anna Nikoghosyan
A. Abollahi
P. Plinkert
Stefan Rieken
M.W. Muenter
D. Juergen
Keywords:
Radiology
Medicine
Cetuximab
Carbon ion
Adenoid cystic carcinoma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]